Sutro Biopharma Inc. (STRO)
NASDAQ: STRO
· Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 07:16 PM EDT
Sutro Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 104.47M | 66.43M | 62.04M | 160.96M | 169.36M | 154.06M | 153.73M | 48.64M | 56.87M | 74.55M | 67.77M | 69.79M | 53.16M | 53.12M | 61.88M | 59.5M | 68.81M | 50.23M |
Cost of Revenue | 1.96M | 1.85M | 3.61M | 7.08M | 5.72M | 6.32M | 6.82M | 7.24M | 8.89M | 8.55M | 36.28M | 36.53M | 61.05M | 84.3M | 76.88M | 97.21M | 89.97M | 81.9M |
Gross Profit | 100.7M | 62.78M | 56.62M | 155.67M | 163.64M | 147.74M | 146.91M | 41.4M | 47.98M | 66M | 31.49M | 33.27M | -7.88M | -31.19M | -15M | -37.71M | -21.16M | -31.67M |
Operating Income | -205.04M | -250.38M | -238.45M | -130.04M | -106.14M | -103.63M | -89.28M | -181.65M | -158.85M | -132.05M | -128.94M | -114.76M | -128.22M | -118.65M | -98.52M | -88.33M | -64.27M | -70.89M |
Interest Income | 36.61M | 39M | 39.91M | 40.61M | 18.11M | 16.05M | 14.51M | 12.08M | 8.54M | 5.9M | 3.46M | 1.42M | 518K | 496K | 577K | 669K | 855K | 1.06M |
Pretax Income | -206.36M | -242.85M | -225.1M | -108.14M | -106.8M | -97.16M | -88.6M | -170.07M | -142.11M | -127.25M | -116.7M | -120.23M | -131.65M | -114.29M | -105.54M | -126.96M | -78.92M | -42.89M |
Net Income | -208.7M | -245.22M | -227.46M | -123.95M | -124.45M | -114.96M | -106.79M | -174.95M | -143.43M | -130.92M | -119.96M | -120.99M | -134.13M | -114.27M | -105.54M | -126.96M | -78.92M | -42.89M |
Selling & General & Admin | 46.98M | 49.01M | 46.69M | 52.73M | 53.67M | 56.3M | 60.85M | 60.5M | 59.87M | 60.02M | 59.54M | 60.59M | 62.53M | 59.94M | 56M | 50.62M | 43.11M | 39.21M |
Research & Development | 223.07M | 246.76M | 252.04M | 234.77M | 218.33M | 197.9M | 180.43M | 169.79M | 155.84M | 146.58M | 137.17M | 123.96M | 118.85M | 111.83M | 104.4M | 97.21M | 89.97M | 81.9M |
Other Expenses | 17.27M | 17.39M | -3.66M | -1.79M | -3.53M | -1.74M | -1.74M | -1.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 287.32M | 313.15M | 295.08M | 285.72M | 268.48M | 252.47M | 239.54M | 228.56M | 215.71M | 206.6M | 196.72M | 184.55M | 181.38M | 171.76M | 160.4M | 147.84M | 133.08M | 121.12M |
Interest Expense | 36.89M | 36.29M | 35.04M | 35.08M | 35.85M | 30.16M | 23.75M | 15.02M | 9.13M | 6.37M | 4.04M | 4.65M | 2.68M | 2.94M | 3.14M | 2.52M | 4.02M | 6.13M |
Selling & Marketing Expenses | n/a | n/a | -1.76M | -3.49M | -3.49M | -3.49M | -1.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 291.11M | 316.83M | 300.52M | 291M | 275.5M | 257.7M | 243.01M | 230.29M | 215.71M | 206.6M | 196.72M | 184.55M | 181.38M | 171.76M | 160.4M | 147.84M | 133.08M | 121.12M |
Income Tax Expense | 2.34M | 2.36M | 2.36M | 15.81M | 17.65M | 17.8M | 18.19M | 4.88M | 1.32M | 3.67M | 3.26M | 756K | 2.48M | -22K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 84.58M | 83.11M | 82.53M | 82.04M | 81.22M | 61.46M | 61.01M | 60.6M | 60.34M | 58.72M | 56.79M | 52.35M | 46.96M | 46.5M | 46.01M | 46.12M | 46.12M | 45.91M |
Shares Outstanding (Diluted) | 84.58M | 83.11M | 82.53M | 82.04M | 81.22M | 61.46M | 61.01M | 60.6M | 60.34M | 58.72M | 56.79M | 52.35M | 46.96M | 46.5M | 46.16M | 46.16M | 46.12M | 45.91M |
EPS (Basic) | -2.52 | -2.97 | -3.01 | -1.62 | -1.84 | -1.89 | -1.79 | -2.95 | -2.48 | -2.39 | -2.38 | -2.56 | -2.89 | -2.47 | -2.29 | -3.07 | -1.94 | -0.81 |
EPS (Diluted) | -2.52 | -2.97 | -3.01 | -1.62 | -1.84 | -1.89 | -1.79 | -2.95 | -2.48 | -2.39 | -2.38 | -2.56 | -2.89 | -2.47 | -2.29 | -3.07 | -1.95 | -0.88 |
EBITDA | -165.38M | -200.97M | -186.81M | -72.28M | -72.68M | -68.88M | -66.51M | -153.94M | -129.09M | -114.82M | -104.38M | -107.05M | -117.56M | -100.88M | -92.63M | -115.89M | -101.52M | -114.49M |
EBIT | -151.62M | -190.47M | -194.03M | -81.95M | -82.28M | -79.09M | -74.73M | -160.7M | -136.19M | -121.57M | -113.36M | -115.58M | -128.97M | -111.35M | -102.4M | -124.43M | -74.89M | -36.76M |
Depreciation & Amortization | 7.47M | 7.36M | 7.22M | 7.08M | 7.02M | 7.63M | 8.12M | 8.55M | 8.89M | 8.55M | 8.29M | 8.53M | 11.41M | 10.48M | 9.77M | 8.54M | 4.55M | 4.49M |